INE794A01010
INE794A01010
NEULAND LABORATORIES LTD.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 19.321.190.000 | 14.343.821.000 | 34.7% |
| Cost of Revenue | 9.471.166.000 | 7.505.080.000 | 26.2% |
| Gross Profit | 9.850.024.000 | 6.838.741.000 | 44.0% |
| 4.949.788.000 | 4.172.964.000 | 18.6% | |
| Operating Income | 4.900.236.000 | 2.665.777.000 | 83.8% |
| Pretax Income | 4.889.771.000 | 3.463.290.000 | 41.2% |
| Net Income Common Stockholders | 3.639.984.000 | 2.601.081.000 | 39.9% |
| -- | -- | -- | |
| -- | -- | -- |